Cite
HARVARD Citation
Vincenti, F. et al. (2018). A randomized, phase 2 study of ASP0113, a DNA‐based vaccine, for the prevention of CMV in CMV‐seronegative kidney transplant recipients receiving a kidney from a CMV‐seropositive donor. American journal of transplantation. 18 (12), pp. 2945-2954. [Online].